Assessment of health-related quality of life (HRQoL) in triple-class-exposed patients with relapsed or refractory multiple myeloma (RRMM) treated with linvoseltamab in the LINKER-MM1 trial

被引：0
|
作者：
Hoffman, James E.
Bumma, Naresh
Richter, Joshua Ryan
Dhodapkar, Madhav V.
Lee, Hans C.
Suvannasankha, Attaya
Zonder, Jeffrey A.
Maly, Joseph J.
Shah, Mansi R.
Baz, Rachid C.
DeVeaux, Michelle
Ivanescu, Cristina
Rodriguez-Lorenc, Karen
Kroog, Glenn Scott
Houvras, Yariv J.
Inocencio, Timothy J.
Chi, Lei
Harnett, James
Ma, Qiufei
Jagannath, Sundar
机构：
[1] Univ Miami Hlth Syst, Miami, FL USA
[2] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH USA
[3] Icahn Sch Med Mt Sinai, New York, NY USA
[4] Emory Univ, Sch Med, Atlanta, GA USA
[5] Univ Texas MD Anderson Canc Ctr, Houston, TX USA
[6] Indiana Univ, Simon Canc Ctr, Indianapolis, IN USA
[7] Indiana Univ, Roudebush VAMC, Indianapolis, IN USA
[8] Karmanos Canc Inst, Detroit, MI USA
[9] Norton Canc Inst, Louisville, KY USA
[10] Rutgers Canc Inst New Jersey, New Brunswick, NJ USA
[11] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[12] Regeneron Pharmaceut Inc, Tarrytown, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e23185
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Health Related Quality of Life (HRQoL) in Relapsed/Refractory Multiple Myeloma (RRMM): A Systematic Literature Review (SLR) and Meta-Analysis
    Banerjee, Rahul
    Hasegawa, Ken
    Itani, Taha
    Giordana, Monique
    Granados, Enrique
    Rosado, Margrit B.
    Chan, Rebecca J.
    Kostic, Ana
    Kanters, Steve
    Zoratti, Michael J.
    Leleu, Xavier
    BLOOD, 2024, 144 : 4721 - 4722
  • [22] HEALTH RELATED QUALITY OF LIFE (HRQOL) IN MULTIPLE MYELOMA (MM) PATIENTS IN BULGARIA
    Georgieva, S.
    Tsvetkova, G.
    Petrova, G.
    Hadjiev, E.
    Haralampieva, T.
    Bekirova, E.
    Angelova, M.
    VALUE IN HEALTH, 2018, 21 : S474 - S474
  • [23] Effects of Idecabtagene Vicleucel ( Ide-Cel) Versus Standard Regimens on Health-Related Quality of Life (HRQoL) in Patients with Triple-Class-Exposed (TCE) Relapsed/Refractory Multiple Myeloma (RRMM) Who Received at Least 3 Lines of Prior Antimyeloma Regimens in the KarMMa-3 Phase 3 Randomized Controlled Trial
    Delforge, Michel
    Patel, Krina K.
    Eliason, Laurie
    Dhanda, Devender
    Shi, Ling
    Guo, Shien
    Marshall, Thomas S.
    Arnulf, Bertrand
    Cavo, Michele
    Nooka, Ajay K.
    Manier, Salomon
    Callander, Natalie S.
    Giralt, Sergio A.
    Einsele, Hermann
    Ailawadhi, Sikander
    Popa-McKiver, Mihaela
    Cook, Mark
    Otero, Paula Rodriguez
    BLOOD, 2023, 142
  • [24] Health-Related Quality of Life in Patients with Relapsed/Refractory Multiple Myeloma Treated with Isatuximab Plus Pomalidomide and Dexamethasone: Icaria-MM Study
    Houghton, Katherine
    Dimopoulos, Meletios A.
    Lin, Peggy
    Guillonneau, Sophie
    Bury, Denise
    Attal, Michel
    Richardson, Paul G.
    Delforge, Michel
    BLOOD, 2019, 134
  • [25] CHARACTERIZING EXPOSURE-RESPONSE RELATIONSHIPS OF IDECABTAGENE VICLEUCEL IN PATIENTS WITH TRIPLE-CLASS-EXPOSED RELAPSED/REFRACTORY MULTIPLE MYELOMA
    Zhou, J.
    Burnett, J.
    Zheng, X.
    Chen, Y.
    Caia, A.
    Cook, M.
    Kondic, A.
    Lamba, M.
    Wu, F.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 : S82 - S82
  • [26] Health-related quality of life with idecabtagene vicleucel in relapsed and refractory multiple myeloma
    Delforge, Michel
    Shah, Nina
    Miguel, Jesus San F.
    Braverman, Julia
    Dhanda, Devender S.
    Shi, Ling
    Guo, Shien
    Yu, Peiwen
    Liao, Weiqin
    Campbell, Timothy B.
    Munshi, Nikhil C.
    BLOOD ADVANCES, 2022, 6 (04) : 1309 - 1318
  • [27] DREAMM-2: Belantamab mafodotin (belamaf; GSK2857916) effect on disease symptoms and health-related quality of life (HRQoL) in patients with relapsed/refractory multiple myeloma (RRMM)
    Weisel, K.
    Popat, R.
    Lonial, S.
    Lee, H.
    Badros, A.
    Trudel, S.
    Nooka, A.
    Chari, A.
    Abdallah, A-O
    Callander, N.
    Sborov, D.
    Suvannasankha, A.
    Voorhees, P.
    Cohen, A.
    Opalinska, J.
    Gutierrez, B.
    Gorsh, B.
    He, Z.
    Eliason, L.
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 (SUPPL 4) : 103 - 104
  • [28] Characteristics And Treatment Patterns of Triple-Class-Exposed Patients With Relapsed/Refractory Multiple Myeloma Who Participated in Clinical Trials of Daratumumab
    Weisel, Katja C.
    Martin, Thomas
    Yong, Kwee
    Qi, Keqin
    Londhe, Anil
    Kobos, Rachel
    Qi, Ming
    Schecter, Jordan M.
    Vogel, Martin
    Valluri, Satish
    Krishnan, Amrita
    Jagannath, Sundar
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 137 - 138
  • [29] Health-related quality of life outcomes in relapsed and/or refractory multiple myeloma: a systematic review
    Sparano, Francesco
    Cavo, Michele
    Niscola, Pasquale
    Efficace, Fabio
    QUALITY OF LIFE RESEARCH, 2016, 25 : 123 - 124
  • [30] Health-related quality of life outcomes from the CANDOR study in patients with relapsed or refractory multiple myeloma
    Siegel, David
    Weisel, Katja
    Zahlten-Kumeli, Anita
    Medhekar, Rohan
    Ding, Bifeng
    Leleu, Xavier
    LEUKEMIA & LYMPHOMA, 2021, 62 (12) : 3002 - 3010
12345